the statement(s) set out in Column 3 of the table must be contained on the labels of the medicine in accordance with the Labelling Order, in a manner that is compliant with any applicable presentation requirement(s) set out below (the requirements are indicated in the table by the presence of the applicable alphabetical in square brackets, next to the statement).
Unless otherwise specified, the requirements apply only if the substance is included in the medicine as an active ingredient.
The wording of the statements specified in Column 3 of Table 1 of this Schedule may be varied provided that the intent is not changed.
Where more than one statement is required, they may be combined to form simple sentences where appropriate, provided that the intent is not changed and that any presentation requirements (see below) are also met.
In some cases, additional requirements apply to advisory statements, such as font, letter size etc. Where such additional requirements apply, they are indicated by a letter in square brackets (e.g. [a]) shown in column 3 of the Table 1 below. The meaning of the letters is set out below:
(i) on a separate line or lines immediately below the cautionary statement “KEEP OUT OF REACH OF CHILDREN”; and
(iii) in letters as least four tenths the height of the letters used for the signal heading; and
(iv) with nothing else besides the statement written on the same line.
(i) be grouped with any other statements marked with this additional requirement; and
(ii) if the heading “SAFETY DIRECTIONS” is required on the label, be included immediately after that heading; or
(iii) if the heading “SAFETY DIRECTIONS” is not required on the label, be included immediately preceding the directions for use.
[k]: Statement(s) must be printed in type of 3 mm height or larger.
[l]: Statement(s) must be printed on the front of the goods.
Column 1 Substance(s) | Column 2 Conditions | Column 3 Required statement(s) |
Acetone | In concentrations greater than 75 per cent | · either - READ SAFETY DIRECTIONS [f] or - READ SAFETY DIRECTIONS BEFORE OPENING AND USING. [f] · SAFETY DIRECTIONS Avoid contact with eyes [h] Avoid contact with skin [h] Avoid breathing [vapour/spray mist]. [h] · DO NOT SWALLOW.[g] |
Actaea racemosa (previous name Cimicifuga racemosa) | In listed medicines | · Warning: In very rare cases, Black cohosh has been associated with liver failure. · If you are experiencing yellowing of the skin or whites of the eyes, dark urine, nausea, vomiting, unusual tiredness, weakness, stomach or abdominal pain, and/or loss of appetite, you should stop using this product and see your doctor. |
Activated charcoal | In listed medicines | · Products containing activated charcoal should be used with caution in children since it may interfere with the absorption of nutrients. · This substance may interact with other medicines. · Activated charcoal is not recommended for long term use. |
Ademetionine | In listed medicines, in the form of sulfate salts, tosylate salts or mixed sulfate and tosylate salts | · Individuals who are using prescription antidepressants or suffer from bipolar depression should not use this product unless under the supervision of a healthcare practitioner. |
(S)-S-Adenosylmethionine | In listed medicines, in the form of sulfate salts, tosylate salts or mixed sulfate and tosylate salts | · Individuals who are using prescription antidepressants or suffer from bipolar depression should not use this product unless under the supervision of a healthcare practitioner. |
Alclometasone | When included in Schedule 3 to the SUSMP | · CAUTION - do not use for children under 2 years old unless a doctor has told you to. [j] · Do not use in the eyes. [j] · Do not use for acne. [j] · Do not use under waterproof bandages unless a doctor has told you to. [j] · Do not use for more than 7 days unless a doctor has told you to. [j] |
Anise oil | For the purpose of exclusion from the schedules to the SUSMP when: a. in preparations containing more than 50 per cent of anise oil; and b. packed in containers having a nominal capacity of 50 millilitres or less, fitted with a restricted flow insert | · KEEP OUT OF REACH OF CHILDREN. [a] |
Antihistamines NB: entry amended in Schedule 2 | When included in a schedule to the SUSMP and NOT separately specified in the table and NOT: a. dermal, ocular or paediatric preparations; or b. oral preparations of desloratadine, loratadine or fexofenadine; or c. nasal preparations of azelastine | either · This medication may cause drowsiness. If affected do not drive a vehicle or operate machinery. Avoid alcohol. [j] or · This medication may cause drowsiness and may increase the effects of alcohol. If affected do not drive a motor vehicle or operate machinery. [j] |
Arginine | In listed medicines | · This medicine contains arginine and is intended to be applied to the skin only and not to the mucosa, vagina or rectum. |
Aspirin (Entry 1 of 7) NB: entry amended in Schedule 2 | For the purpose of exclusion from the schedules to the SUSMP when: a. each dosage unit contains MORE than 100 milligrams of aspirin; and b. the preparation is NOT indicated for the prevention of cardiovascular disease or for the inhibition of platelet aggregation | · Do not use [this product/insert name of product] during the first 6 months of pregnancy, except on doctor’s advice. Do not use at all during the last 3 months of pregnancy. · Do not use [this product/insert name of product] if you have a stomach ulcer. · Do not use [this product/insert name of product] if you are allergic to aspirin or other anti-inflammatory medicines. · Unless a doctor has told you to, do not use [this product/insert name of product] for more than a few days at a time. · Unless a doctor has told you to, do not use [this product/insert name of product] in children under 12 years of age. · Unless a doctor has told you to, do not use [this product/insert name of product] in children 12 to 16 years of age with or recovering from chicken pox, influenza or fever. · Unless a doctor has told you to, do not use [this product/insert name of product] if you have asthma. · either - Unless a doctor has told you to, do not use [this product/insert name of product] with other medicines containing aspirin or other anti-inflammatory medicines. or - Unless advised by your doctor or pharmacist, do not use [this product/insert name of product] with other products containing aspirin or anti-inflammatory medicines or with medicines that you are taking regularly. · See a doctor before taking [this product/insert name of product] for thinning the blood or for your heart. |
Aspirin (Entry 2 of 7) NB: entry amended in Schedule 2 | For the purpose of exclusion from the schedules to the SUSMP when: a. each dosage unit contains MORE than 100 milligrams of aspirin; and b. the preparation IS indicated for the prevention of cardiovascular disease or for the inhibition of platelet aggregation | · Do not use [this product/insert name of product] during the first 6 months of pregnancy, except on doctor’s advice. Do not use at all during the last 3 months of pregnancy. · Do not use [this product/insert name of product] if you have a stomach ulcer. · Do not use [this product/insert name of product] if you are allergic to aspirin or other anti-inflammatory medicines. · Unless a doctor has told you to, do not use [this product/insert name of product] in children under 12 years of age. · Unless a doctor has told you to, do not use [this product/insert name of product] in children 12 to 16 years of age with or recovering from chicken pox, influenza or fever. · Unless a doctor has told you to, do not use [this product/insert name of product] if you have asthma. · either - Unless a doctor has told you to, do not use [this product/insert name of product] with other medicines containing aspirin or other anti-inflammatory medicines. or - Unless advised by your doctor or pharmacist, do not use [this product/insert name of product] with other products containing aspirin or anti-inflammatory medicines or with medicines that you are taking regularly. |
Aspirin (Entry 3 of 7) NB: entry amended in Schedule 2 | For the purpose of exclusion from the schedules to the SUSMP, when: a. each dosage unit contains 100 milligrams or LESS of aspirin, and: b. the preparation IS indicated for the prevention of cardiovascular disease or for inhibition of platelet aggregation | · For use under medical supervision only. |
Aspirin (Entry 4 of 7) NB: entry amended in Schedule 2 | When included in a schedule to the SUSMP and: a. the preparation IS indicated for the prevention of cardiovascular disease or for the inhibition of platelet aggregation; or b. in sustained release preparations containing 650 milligrams or more of aspirin | · For use under medical supervision only. [j] |
Aspirin (Entry 5 of 7) NB: entry amended in Schedule 2 | When included in a schedule to the SUSMP, and: a. the preparation IS indicated exclusively for treatment of dysmenorrhoea; and b. NOT in sustained release preparations containing 650 milligrams or more of aspirin; and c. NOT in combination with other therapeutically active substances (other than effervescent agents) | · Do not use [this product/insert name of product] if you have a stomach ulcer. · Do not use [this product/insert name of product] if you are allergic to aspirin or other anti-inflammatory medicines. · Unless a doctor has told you to, do not use [this product/insert name of product] for more than a few days at a time. · Unless a doctor has told you to, do not use [this product/insert name of product] in children under 12 years of age. · Unless a doctor has told you to, do not use [this product/insert name of product] in children 12 to 16 years of age with or recovering from chicken pox, influenza or fever. · Unless a doctor has told you to, do not use [this product/insert name of product] if you have asthma. · either - Unless a doctor has told you to, do not use [this product/insert name of product] with other medicines containing aspirin or other anti-inflammatory medicines. or - Unless advised by your doctor or pharmacist, do not use [this product/insert name of product] with other products containing aspirin or anti-inflammatory medicines or with medicines that you are taking regularly. · See a doctor before taking [this product/insert name of product] for thinning the blood or for your heart. |
Aspirin (Entry 6 of 7) NB: entry amended in Schedule 2 | When included in a schedule to the SUSMP, and: a. in combination with other therapeutically active substances (other than effervescent agents); and b. NOT in sustained release preparations containing 650 milligrams or more of aspirin; and c. the preparation is NOT indicated: i. for the prevention of cardiovascular disease or for the inhibition of platelet aggregation; or ii. exclusively for treatment of dysmenorrhoea | · Do not use [this product/insert name of product] during the first 6 months of pregnancy, except on doctor’s advice. Do not use at all during the last 3 months of pregnancy. · Do not use [this product/insert name of product] if you have a stomach ulcer. · Do not use [this product/insert name of product] if you are allergic to aspirin or other anti-inflammatory medicines. · Unless a doctor has told you to, do not use [this product/insert name of product] for more than a few days at a time. · Unless a doctor has told you to, do not use [this product/insert name of product] in children under 12 years of age. · Unless a doctor has told you to, do not use [this product/insert name of product] in children 12 to 16 years of age with or recovering from chicken pox, influenza or fever. · Unless a doctor has told you to, do not use [this product/insert name of product] if you have asthma. · either - Unless a doctor has told you to, do not use [this product/insert name of product] with other medicines containing aspirin or other anti-inflammatory medicines. or - Unless advised by your doctor or pharmacist, do not use [this product/insert name of product] with other products containing aspirin or anti-inflammatory medicines or with medicines that you are taking regularly. |
Aspirin (Entry 7 of 7) NB: entry amended in Schedule 2 | When included in a schedule to the SUSMP and: a. NOT in combination with other therapeutically active substances (other than effervescent agents); and b. NOT in sustained release preparations containing 650 milligrams or more of aspirin; and c. the preparation is NOT indicated: i. for the prevention of cardiovascular disease or for the inhibition of platelet aggregation; or ii. exclusively for treatment of dysmenorrhoea | · Do not use [this product/insert name of product] during the first 6 months of pregnancy, except on doctor’s advice. Do not use at all during the last 3 months of pregnancy. · Do not use [this product/insert name of product] if you have a stomach ulcer. · Do not use [this product/insert name of product] if you are allergic to aspirin or other anti-inflammatory medicines. · Unless a doctor has told you to, do not use [this product/insert name of product] for more than a few days at a time. · Unless a doctor has told you to, do not use [this product/insert name of product] in children under 12 years of age. · Unless a doctor has told you to, do not use [this product/insert name of product] in children 12 to 16 years of age with or recovering from chicken pox, influenza or fever. · Unless a doctor has told you to, do not use [this product/insert name of product] if you have asthma. · either - Unless a doctor has told you to, do not use [this product/insert name of product] with other medicines containing aspirin or other anti-inflammatory medicines. or - Unless advised by your doctor or pharmacist, do not use [this product/insert name of product] with other products containing aspirin or anti-inflammatory medicines or with medicines that you are taking regularly. · See a doctor before taking [this product/insert name of product] for thinning the blood or for your heart. |
Azadirachta indica (Neem) (Entry 1 of 2) | When: a. in listed medicines containing more than 1% of cold pressed neem seed oil; or b. for the purpose of exclusion from the schedules to the SUSMP when in preparations for dermal use and in a container fitted with a child resistant closure | · Not to be taken. · Keep out of reach of children. · Do not use if pregnant or likely to become pregnant. |
Azadirachta indica including its extracts and derivatives (Entry 2 of 2) | When included in Schedule 6 to the SUSMP | · Do not use if pregnant or likely to become pregnant. [j] |
Backhousia citriodora | In listed medicines | · Not recommended for use by children aged 12 years or under. · Not recommended for use by pregnant or lactating women. · If skin irritation occurs, discontinue use. |
Basil oil | For the purpose of exclusion from the schedules to the SUSMP when: a. in preparations or oils containing more than 5 per cent of methyl chavicol; and b. packed in containers having a nominal capacity of 25 millilitres or less, fitted with a restricted flow insert | · KEEP OUT OF REACH OF CHILDREN. [a] |
Bay oil | For the purpose of exclusion from the schedules to the SUSMP when: a. in preparations containing more than 25 per cent of bay oil; and b. packed in containers having: i. a nominal capacity of 15 millilitres or less, fitted with a restricted flow insert; or ii. a nominal capacity of 25 millilitres or less, fitted with a restricted flow insert and child-resistant closure | · KEEP OUT OF REACH OF CHILDREN. [a] · NOT TO BE TAKEN. [a] |
Benzoyl peroxide | When included in Schedule 2 to the SUSMP | · Keep from eyes, lips, mouth and sensitive areas of the neck. [j] · If excessive swelling, irritation, redness or peeling occurs, discontinue use. [j] · If these persist, consult a physician. [j] · Avoid excessive exposure to sunlight and other sources of ultra violet light. [j] |
Bergamot oil | For the purpose of exclusion from the schedules to the SUSMP; or when included in a schedule to the SUSMP | · Application to skin may increase sensitivity to sunlight. [j] |
Bovine colostrum powder | In listed medicines | · Products containing bovine colostrum powder contain lactose and cow’s milk proteins. · This product is not suitable for use in children under the age of 12 months except on professional health advice. |
Bovine lactoferrin | In listed medicines | · Derived from cow’s milk. |
Caffeine (Entry 1 of 2) | In listed medicines, except medicines containing less than 1 milligram of caffeine in the MRDD: a. for oral or sublingual administration; and b. the MRDD of which contains 10 milligrams OR LESS of caffeine or less; and c. when the caffeine is from a herbal source | · The recommended dose of this medicine provides small amounts of caffeine. |
Caffeine (Entry 2 of 2) | In listed medicines: a. for oral or sublingual administration; and b. the MRDD of which contains MORE THAN 10 milligrams of caffeine; and c. when the caffeine is from a herbal source | · Contains [amount of caffeine in milligrams] mg of caffeine. |
Cajuput oil | For the purpose of exclusion from the schedules to the SUSMP when: a. in preparations or oils containing more than 25 per cent of cajuput oil; and b. packed in containers having: i. a nominal capacity of 15 millilitres or less, fitted with a restricted flow insert; or ii. a nominal capacity of 25 millilitres or less, fitted with a restricted flow insert and child-resistant closure | · KEEP OUT OF REACH OF CHILDREN. [a] · NOT TO BE TAKEN. [a] |
Calcium sodium caseinate | In listed medicines | Either · Derived from cow’s milk. or · Contains cow’s milk protein. |
Camphor (Entry 1 of 3) NB: entry amended in Schedule 2 | For the purpose of exclusion from the schedules to the SUSMP when: a. included as a natural component in essential oils containing more than 2.5 per cent of camphor but 10 per cent or less of camphor; and b. packed in containers having a nominal capacity of 25 millilitres or less, fitted with a restricted flow insert | · KEEP OUT OF REACH OF CHILDREN. [a] · NOT TO BE TAKEN. [a] |
Camphor (Entry 2 of 3) NB: entry amended in Schedule 2 | For the purpose of exclusion from the schedules to the SUSMP when: a. in essential oils when the camphor is present as a natural component of the oil; and b. packed in containers having: i. a nominal capacity of 15 millilitres or less, fitted with a restricted flow insert; or ii. a nominal capacity of 25 millilitres or less, fitted with a restricted flow insert and child-resistant closure | · KEEP OUT OF REACH OF CHILDREN. [a] · NOT TO BE TAKEN. [a] |
Camphor (Entry 3 of 3) | When: i. included in a schedule to the SUSMP, and ii. not in block, ball or pellet form, enclosed in a device which, in normal use, prevents removal or ingestion of its contents. | · Either - READ SAFETY DIRECTIONS [f] or - READ SAFETY DIRECTIONS BEFORE OPENING AND USING. [f] · SAFETY DIRECTIONS Can be fatal to children if sucked or swallowed. [j] Avoid contact with eyes. [h] |
Canarium indicum | In listed medicines | · This product contains material derived from nuts. |
Cassia oil | When included in a Schedule to the SUSMP | · either - READ SAFETY DIRECTIONS [f] or - READ SAFETY DIRECTIONS BEFORE OPENING AND USING. [f] · SAFETY DIRECTIONS Avoid contact with skin. [h] · DO NOT SWALLOW. [g] |
Charcoal – activated | In listed medicines | · Products containing activated charcoal should be used with caution in children since it may interfere with the absorption of nutrients. · This substance may interact with other medicines. · Activated charcoal is not recommended for long term use. |
Chelidonium majus | When the preparation is for oral use | · Warning: Greater Celandine may harm the liver in some people. · Use only under the supervision of a healthcare professional. |
Chromates (including dichromates) of alkali metals or ammonia | When included in a schedule to the SUSMP | · either - READ SAFETY DIRECTIONS [f] or - READ SAFETY DIRECTIONS BEFORE OPENING AND USING. [f] · SAFETY DIRECTIONS Avoid contact with eyes [h] Avoid contact with skin [h] Avoid breathing [dust]/[vapour]/[ spray mist]. [h] |
Cimetidine | When included in Schedule 3 to the SUSMP | · Use only under medical supervision if you are taking other medicines. [j] · CAUTION: This preparation is for the relief of minor and temporary ailments and should be used strictly as directed. [j] · If symptoms persist or recur within two weeks of completing the course, consult a doctor. [j] |
Cineole | For the purpose of exclusion from the schedules to the SUSMP when: a. in preparations or oils containing more than 25 per cent of cineole (other than rosemary oil or camphor oil); and b. packed in containers having: i. a nominal capacity of 15 millilitres or less, fitted with a restricted flow insert; or ii. a nominal capacity of 25 millilitres or less, fitted with a restricted flow insert and child-resistant closure | · KEEP OUT OF REACH OF CHILDREN. [a] · NOT TO BE TAKEN. [a] |
Cinnamon bark oil | When included in a schedule to the SUSMP | · either - READ SAFETY DIRECTIONS [f] or - READ SAFETY DIRECTIONS BEFORE OPENING AND USING. [f] · SAFETY DIRECTIONS Avoid contact with skin. [h] · DO NOT SWALLOW. [g] |
Cinnamon leaf oil | For the purpose of exclusion from the schedules to the SUSMP when: a. in preparations containing more than 25 per cent of cinnamon leaf oil; and b. packed in containers having: i. a nominal capacity of 15 millilitres or less, fitted with a restricted flow insert; or ii. a nominal capacity of 25 millilitres or less, fitted with a restricted flow insert and child-resistant closure | · KEEP OUT OF REACH OF CHILDREN. [a] · NOT TO BE TAKEN. [a] |
Clobetasone | In Schedule 3 to the SUSMP | · Do not use in the eyes. [j] · Do not use for acne. [j] · Do not use under waterproof bandages unless a doctor has told you to. [j] · Do not use for more than 7 days unless a doctor has told you to. [j] · CAUTION - Do not use for children under 12 years old unless a doctor has told you to. [j] |
Clotrimazole | In preparations for vaginal use | · Seek medical advice before first course of treatment. [j] · See a doctor if you are pregnant or diabetic. [j] · See a doctor if no better after [Insert number of days as per approved Product Information] days. [j] · See a doctor if problem returns. [j] |
Clove oil (Entry 1 of 2) | For the purpose of exclusion from the schedules to the SUSMP when: a. in preparations containing more than 25 per cent of clove oil; and b. packed in containers having: i. a nominal capacity of 15 millilitres or less, fitted with a restricted flow insert; or ii. a nominal capacity of 25 millilitres or less, fitted with a restricted flow insert and child-resistant closure | · KEEP OUT OF REACH OF CHILDREN. [j] · NOT TO BE TAKEN. [j] |
Clove oil (Entry 2 of 2) | When included in a Schedule to the SUSMP | · either - READ SAFETY DIRECTIONS [f] or - READ SAFETY DIRECTIONS BEFORE OPENING AND USING. [f] · SAFETY DIRECTIONS Avoid contact with eyes. [h] · DO NOT SWALLOW. [g] |
Colostrum powder – bovine | In listed medicines | · Products containing bovine colostrum powder contain lactose and cow’s milk proteins. · This product is not suitable for use in children under the age of 12 months except on professional health advice. |
Creatine | In listed medicines | · Seek professional advice before long term use. |
Creatine monohydrate | In listed medicines | · Seek professional advice before long term use. |
Creatine phosphate | In listed medicines | · Seek professional advice before long term use. |
Diclofenac (Entry 1 of 2) NB: entry amended in Schedule 2 | When included in a Schedule to the SUSMP and: a. indicated exclusively for the treatment of dysmenorrhoea | · Do not use [this product/insert name of product] if you have a stomach ulcer. [j] · Do not use [this product/insert name of product] if you are allergic to diclofenac or other anti-inflammatory medicines. [j] · Unless a doctor has told you to, do not use [this product/insert name of product] if you have asthma. [j] · either - Unless a doctor has told you to, do not use [this product/insert name of product] with other medicines containing diclofenac or other anti-inflammatory medicines. [j] or - Unless advised by your doctor or pharmacist, do not use [this product/insert name of product] with other products containing diclofenac, aspirin or other anti-inflammatory medicines or with medicines that you are taking regularly. [j] · If you get an allergic reaction, stop taking and see your doctor immediately. [j] · Do not use for more than a few days at a time unless a doctor has told you to. Do not exceed the recommended dose. Excessive use can be harmful. [j] |
Diclofenac (Entry 2 of 2) NB: entry amended in Schedule 2 | When included in a Schedule to the SUSMP and: a. NOT indicated exclusively for the treatment of dysmenorrhoea | · Do not use [this product/insert name of product] if you have a stomach ulcer. [j] · Do not use [this product/insert name of product] if you are allergic to diclofenac or other anti-inflammatory medicines. [j] · Unless a doctor has told you to, do not use [this product/insert name of product] if you have asthma. [j] · either - Unless a doctor has told you to, do not use [this product/insert name of product] with other medicines containing diclofenac or other anti-inflammatory medicines. [j] or - Unless advised by your doctor or pharmacist, do not use [this product/insert name of product] with other products containing diclofenac, aspirin or other anti-inflammatory medicines or with medicines that you are taking regularly. [j] · If you get an allergic reaction, stop taking and see your doctor immediately. [j] · Do not use for more than a few days at a time unless a doctor has told you to. Do not exceed the recommended dose. Excessive use can be harmful. [j] · Do not use [this product/insert name of product] during the first 6 months of pregnancy, except on doctor’s advice. Do not use at all during the last 3 months of pregnancy. [j] |
Diethyltoluamide (DEET) | All, including where present as an excipient | · WARNING - May be dangerous, particularly to children, if you use large amounts on the skin, clothes or bedding or on large areas of the body, especially if you keep using it for a long time. [j] |
Diphenoxylate NB: entry amended in Schedule 2 | In medicines for oral use | · either · This medication may cause drowsiness. If affected do not drive a vehicle or operate machinery. Avoid alcohol. [j] or · This medication may cause drowsiness and may increase the effects of alcohol. If affected do not drive a motor vehicle or operate machinery. [j] · Do not give to children under 12 years of age. [j] · either · Do not use beyond 48 hours or in pregnancy or lactation except on doctor’s advice. [j] or · If the condition persists after two days of treatment seek medical advice as soon as possible. [j] and · Do not use during pregnancy or breastfeeding unless advised by your doctor or pharmacist. [j] |
Econazole | In preparations for vaginal use | · Seek medical advice before first course of treatment. [j] · See a doctor if you are pregnant or diabetic. [j] · See a doctor if no better after [Insert number of days as per approved Product Information] days. [j] · See a doctor if problem returns. [j] |
Eucalyptus oil | For the purpose of exclusion from the schedules to the SUSMP when: a. in preparations containing more than 25 per cent of eucalyptus oil; and b. packed in containers having: i. a nominal capacity of 15 millilitres or less, fitted with a restricted flow insert; or ii. a nominal capacity of 25 millilitres or less, fitted with a restricted flow insert and child-resistant closure | · KEEP OUT OF REACH OF CHILDREN. [a] · NOT TO BE TAKEN. [a] |
Eugenol (Entry 1 of 2) | For the purpose of exclusion from the schedules to the SUSMP when: a. in preparations containing more than 25 per cent of eugenol; and b. packed in containers having: i. a nominal capacity of 15 millilitres or less, fitted with a restricted flow insert; or ii. a nominal capacity of 25 millilitres or less, fitted with a restricted flow insert and child-resistant closure | · KEEP OUT OF REACH OF CHILDREN. [a] · NOT TO BE TAKEN. [a] |
Eugenol (Entry 2 of 2) | When included in a Schedule to the SUSMP | · either - READ SAFETY DIRECTIONS [f] or - READ SAFETY DIRECTIONS BEFORE OPENING AND USING. [f] · SAFETY DIRECTIONS Avoid contact with eyes. [h] · DO NOT SWALLOW. [g] |
Fallopia multiflora (previous name Polygonum multiflorum) NB: entry amended in Schedule 2 | In listed medicines | · either - Warning: Polygonum multiflorum may harm the liver in some people. or - Warning: Fallopia multiflora may harm the liver in some people. · Use under the supervision of a healthcare professional. |
Famotidine | In medicines for oral use | · CAUTION - This preparation is for the relief of minor and temporary ailments and should be used strictly as directed. [j] · If symptoms persist or recur within two weeks of completing the course, consult a doctor. [j] |
Fluconazole NB: entry amended in Schedule 2 | In medicines for oral use | · See a doctor if no better after [Insert number of days as per approved Product Information] days. [j] |
Fluorides | For the purpose of exclusion from the schedules to the SUSMP when: a. in dental hygiene products (other than pastes, powders or gels for the cleaning of teeth); and b. the preparation contains 220 milligrams per kilogram or 220 milligrams per litre or less of fluoride ion; and c. in packs containing not more than 120 milligrams total fluoride, fitted with a child-resistant closure | · Do not swallow. [j] · Do not use [this product/insert name of product] in children 6 years of age or less. [j] |
Flurbiprofen NB: entry amended in Schedule 2 | When included in a schedule to the SUSMP | · Do not use [this product/insert name of product] if you have a stomach ulcer. [j] · Do not use [this product/insert name of product] if you are allergic to flurbiprofen or other anti-inflammatory medicines. [j] · Unless a doctor has told you to, do not use [this product/insert name of product] if you have asthma. [j] · either - Unless a doctor has told you to, do not use [this product/insert name of product] with other medicines containing flurbiprofen or other anti-inflammatory medicines. [j] or - Unless advised by your doctor or pharmacist, do not use [this product/insert name of product] with other products containing flurbiprofen, aspirin or other anti-inflammatory medicines or with medicines that you are taking regularly. [j] · If you get an allergic reaction, stop taking and see your doctor immediately. [j] · Do not use for more than a few days at a time unless a doctor has told you to. Do not exceed the recommended dose. Excessive use can be harmful. [j] · either - Do not use [this product/insert name of product] during the first 6 months of pregnancy, except on doctor’s advice. Do not use at all during the last 3 months of pregnancy. or - Do not use during the last three months of pregnancy. and - Unless a doctor has told you to, do not use [this product/insert name of product] if you are pregnant. [j] |
Glucosamine hydrochloride | In listed medicines, when derived from a marine source | · Derived from seafood. |
Glucosamine sulfate | In listed medicines, when derived from a marine source | · Derived from seafood. |
Glucosamine sulfate potassium chloride complex (Entry 1 of 2) | In listed medicines, when derived from a marine source | · Derived from seafood. |
Glucosamine sulfate potassium chloride complex (Entry 2 of 2) | In listed medicines for oral use | · Keep out of reach of children. · Contains [amount of potassium] potassium. · If you have kidney disease or are taking heart or blood pressure medicines, consult your doctor or pharmacist before use. |
Glucosamine sulfate sodium chloride complex | In listed medicines, when derived from a marine source | · Derived from seafood. |
Hexachlorophane | In preparations for skin cleansing purposes containing 3 per cent or less of hexachlorophane | · For external washing only. [j] · Rinse skin thoroughly after use. [j] |
High selenium yeast NB: Entry amended in Schedule 2 | In listed medicines | · This product contains selenium which is toxic in high doses. · A daily dose of 150 micrograms for adults of selenium from dietary supplements should not be exceeded. |
Honey | In listed medicines | · Not suitable for infants under 12 months. |
Hydrocortisone (Entry 1 of 2) | In preparations for dermal use | · CAUTION - Do not use for children under 2 years old unless a doctor has told you to. [j] · Do not use in the eyes. [j] · Do not use for acne. [j] · Do not use under waterproof bandages unless a doctor has told you to. [j] · Do not use for more than 7 days unless a doctor has told you to. [j] |
Hydrocortisone (Entry 2 of 2) | For topical rectal use when included in Schedule 3 to the SUSMP | · CAUTION - Do not use for children under 2 years old unless a doctor has told you to. [j] · Do not use for more than 7 days unless a doctor has told you to. [j] |
Hydrofluoric acid (including mixtures that generate hydrofluoric acid) (Entry 1 of 2) | In Schedule 5 to the SUSMP | · either - READ SAFETY DIRECTIONS [f] or - READ SAFETY DIRECTIONS BEFORE OPENING AND USING. [f] · SAFETY DIRECTIONS Corrosive. [j] Avoid contact with eyes. [h] Avoid contact with skin. [h] · DO NOT SWALLOW. [g] |
Hydrofluoric acid (including mixtures that generate hydrofluoric acid) (Entry 2 of 2) | In Schedule 6 or Schedule 7 to the SUSMP | · either - READ SAFETY DIRECTIONS [f] or - READ SAFETY DIRECTIONS BEFORE OPENING AND USING. [f] · SAFETY DIRECTIONS Highly corrosive [j] Contact with eyes even for short periods can cause blindness [j] Causes severe burns, which are not likely to be immediately painful or visible [j] Avoid contact with eyes [h] Avoid contact with skin [h] Wear protective gloves when mixing or using [h] Avoid breathing [dust/vapour/spray mist] [h] Obtain a supply of calcium gluconate gel. [h] |
Hydrogen peroxide (Entry 1 of 3) | In concentrations of more than 3 per cent up to 10 per cent | · either - READ SAFETY DIRECTIONS [f] or - READ SAFETY DIRECTIONS BEFORE OPENING AND USING. [f] · SAFETY DIRECTIONS Irritant [j] Avoid contact with eyes. [h] · DO NOT SWALLOW. [g] |
Hydrogen peroxide (Entry 2 of 3) | In concentrations of more than 10 per cent up to 20 per cent | · either - READ SAFETY DIRECTIONS [f] or - READ SAFETY DIRECTIONS BEFORE OPENING AND USING. [f] · SAFETY DIRECTIONS Irritant [j] Attacks eyes - protect eyes when using. [h] |
Hydrogen peroxide (Entry 3 of 3) | In concentrations of more than 20 per cent | · either - READ SAFETY DIRECTIONS [f] or - READ SAFETY DIRECTIONS BEFORE OPENING AND USING. [f] · SAFETY DIRECTIONS Attacks eyes - protect eyes when using [h] Avoid contact with skin. [h] · Corrosive. [j] |
Hydroquinone NB: entry amended in Schedule 2 | In Schedule 2 to the SUSMP | · WARNING - If a pigmented spot or mole has recently become darker, changed colour, become enlarged or itchy, or bleeds, do not use this product, see your doctor immediately. [j] · Do not use on children. [j] · Do not use near the eyes. [j] · Mild irritation may occur; stop use if it becomes severe. [j] · If fading is not evident in three months, seek doctor’s advice. [j] |
8-Hydroxyquinoline (including salts and derivatives) | In preparations for internal use | · Do not take for periods longer than four weeks except on medical advice. [j] |
Hypericum perforatum | In listed medicines for oral use | · St John’s Wort affects the way many prescription medicines work, including oral contraceptives. · Consult your doctor. |
Ibuprofen (Entry 1 of 4) NB: entry amended in Schedule 2 | For the purpose of exclusion from the schedules to the SUSMP when: a. the preparation is for oral use; and b. the preparation is indicated exclusively for the treatment of dysmenorrhoea | · Do not use [this product/insert name of product] if you have a stomach ulcer. · Do not use [this product/insert name of product] if you are allergic to ibuprofen or other anti-inflammatory medicines. · Unless a [doctor / doctor or pharmacist] has told you to, do not use [this product / insert name of product] with other medicines containing ibuprofen, aspirin or other anti-inflammatory medicines, or other medicines that you are taking regularly. · Unless a doctor has told you to, do not use [this product/insert name of product] if you have asthma. · If you get an allergic reaction, stop taking and see your doctor immediately. · Do not use for more than a few days at a time unless a doctor has told you to. Do not exceed the recommended dose. Excessive use can be harmful. |
Ibuprofen (Entry 2 of 4) NB: entry amended in Schedule 2 | For the purpose of exclusion from the schedules to the SUSMP, when: a. the preparation is for oral use; and b. the preparation is NOT indicated exclusively for the treatment of dysmenorrhoea | · Do not use [this product/insert name of product] if you have a stomach ulcer. · Do not use [this product/insert name of product] if you are allergic to ibuprofen or other anti-inflammatory medicines. · Unless a [doctor / doctor or pharmacist] has told you to, do not use [this product / insert name of product] with other medicines containing ibuprofen, aspirin or other anti-inflammatory medicines, or other medicines that you are taking regularly. · Unless a doctor has told you to, do not use [this product/insert name of product] if you have asthma. · Unless a doctor has told you to, do not use [this product/insert name of product] in children 6 years of age or less. · Unless a doctor has told you to, do not use [this product/insert name of product] if you are aged 65 years or over. · If you get an allergic reaction, stop taking and see your doctor immediately. · Do not use for more than a few days at a time unless a doctor has told you to. Do not exceed the recommended dose. Excessive use can be harmful. · Do not use [this product/insert name of product] during the first 6 months of pregnancy, except on doctor’s advice. Do not use at all during the last 3 months of pregnancy. |
Ibuprofen (Entry 3 of 4) NB: entry amended in Schedule 2 | When included in a schedule to the SUSMP and a. the preparation is indicated exclusively for the treatment of dysmenorrhoea | · Do not use [this product/insert name of product] if you have a stomach ulcer. [j] · Do not use [this product/insert name of product] if you are allergic to ibuprofen or other anti-inflammatory medicines. [j] · Unless a doctor has told you to, do not use [this product/insert name of product] if you have asthma. [j] · either - Unless a doctor has told you to, do not use [this product/insert name of product] with other medicines containing ibuprofen or other anti-inflammatory medicines. [j] or - Unless advised by your doctor or pharmacist, do not use [this product/insert name of product] with other products containing ibuprofen, aspirin or other anti-inflammatory medicines or with medicines that you are taking regularly. [j] · If you get an allergic reaction, stop taking and see your doctor immediately. [j] · Do not use for more than a few days at a time unless a doctor has told you to. Do not exceed the recommended dose. Excessive use can be harmful. [j] |
Ibuprofen (Entry 4 of 4) NB: entry amended in Schedule 2 | When included in a schedule to the SUSMP and a. the preparation is NOT indicated exclusively for the treatment of dysmenorrhoea | · Do not use [this product/insert name of product] if you have a stomach ulcer. [j] · Do not use [this product/insert name of product] if you are allergic to ibuprofen or other anti-inflammatory medicines. [j] · Unless a doctor has told you to, do not use [this product/insert name of product] if you have asthma. [j] · either - Unless a doctor has told you to, do not use [this product/insert name of product] with other medicines containing ibuprofen or other anti-inflammatory medicines. [j] or - Unless advised by your doctor or pharmacist, do not use [this product/insert name of product] with other products containing ibuprofen, aspirin or other anti-inflammatory medicines or with medicines that you are taking regularly. [j] · If you get an allergic reaction, stop taking and see your doctor immediately. [j] · Do not use for more than a few days at a time unless a doctor has told you to. Do not exceed the recommended dose. Excessive use can be harmful. [j] · Do not use [this product/insert name of product] during the first 6 months of pregnancy, except on doctor’s advice. Do not use at all during the last 3 months of pregnancy. [j] |
Iodine NB: entry amended in Schedule 2 | In preparations for internal use containing 300 micrograms or more of iodine per recommended daily dose | · CAUTION - Total iodine intake may exceed recommended level when taking this preparation. [j] · WARNING - Contains iodine - do not take when pregnant except on physician’s advice. [j] |
Ipratropium bromide | In metered aerosols | · This preparation should be part of an overall treatment plan regularly assessed with your doctor. [j] |
Ketoprofen (Entry 1 of 2) NB: entry amended in Schedule 2 | In preparations for oral use indicated exclusively for the treatment of dysmenorrhoea | · Do not use [this product/insert name of product] if you have a stomach ulcer. [j] · Do not use [this product/insert name of product] if you are allergic to ketoprofen or other anti-inflammatory medicines. [j] · Unless a doctor has told you to, do not use [this product/insert name of product] if you have asthma. [j] · either - Unless a doctor has told you to, do not use [this product/insert name of product] with other medicines containing ketoprofen or other anti-inflammatory medicines. [j] or - Unless advised by your doctor or pharmacist, do not use [this product/insert name of product] with other products containing ketoprofen, aspirin or other anti-inflammatory medicines or with medicines that you are taking regularly. [j] · If you get an allergic reaction, stop taking and see your doctor immediately. [j] · Do not use for more than a few days at a time unless a doctor has told you to. Do not exceed the recommended dose. Excessive use can be harmful. [j] |
Ketoprofen (Entry 2 of 2) NB: entry amended in Schedule 2 | In preparations for oral use that are NOT indicated exclusively for the treatment of dysmenorrhoea | · Do not use [this product/insert name of product] if you have a stomach ulcer. [j] · Do not use [this product/insert name of product] if you are allergic to ketoprofen or other anti-inflammatory medicines. [j] · Unless a doctor has told you to, do not use [this product/insert name of product] if you have asthma. [j] · either - Unless a doctor has told you to, do not use [this product/insert name of product] with other medicines containing ketoprofen or other anti-inflammatory medicines. [j] or - Unless advised by your doctor or pharmacist, do not use [this product/insert name of product] with other products containing ketoprofen, aspirin or other anti-inflammatory medicines or with medicines that you are taking regularly. [j] · If you get an allergic reaction, stop taking and see your doctor immediately. [j] · Do not use for more than a few days at a time unless a doctor has told you to. Do not exceed the recommended dose. Excessive use can be harmful. [j] · Do not use [this product/insert name of product] during the first 6 months of pregnancy, except on doctor’s advice. Do not use at all during the last 3 months of pregnancy. [j] |
Kunzea ambigua NB: entry amended in Schedule 2 | In listed medicines when the preparation is “essential oil” | · For external use only. · Keep out of reach of children. · Not to be applied undiluted to the skin except on the advice of a health care practitioner. |
Lactoferrin – bovine | In listed medicines | · Derived from cow’s milk. |
Larrea tridentata | In listed medicines | · Warning: Chaparral may harm the liver in some people. · Use only under the supervision of a healthcare professional. |
Lemon oil | For the purpose of exclusion from the schedules to the SUSMP | · Application to skin may increase sensitivity to sunlight. [j] |
Levocabastine (Entry 1 of 2) | In eye or nasal preparations containing 0.5 milligrams per millilitre or less of levocabastine | · Do not use if pregnant. [j] |
Levocabastine (Entry 2 of 2) | In eye or nasal preparations containing MORE THAN 0.5 milligrams per millilitre of levocabastine | · Do not use if pregnant. [j] · either · This medication may cause drowsiness. If affected do not drive a vehicle or operate machinery. Avoid alcohol. [j] or · This medication may cause drowsiness and may increase the effects of alcohol. If affected do not drive a motor vehicle or operate machinery. [j] |
Lime oil | For the purpose of exclusion from the schedules to the SUSMP | · Application to skin may increase sensitivity to sunlight. [j] |
Loperamide hydrochloride NB: entry amended in Schedule 2 | In Schedule 2 to the SUSMP | · Do not give to children under 12 years of age. [j] · either · Do not use beyond 48 hours or in pregnancy or lactation except on doctor’s advice. [j] or · If the condition persists after two days of treatment seek medical advice as soon as possible. [j] and · Do not use during pregnancy or breastfeeding unless advised by your doctor or pharmacist. [j] |
Marjoram oil | For the purpose of exclusion from the schedules to the SUSMP when: a. in preparations containing more than 50 per cent of marjoram oil; and b. packed in containers having a nominal capacity of 50 millilitres or less, fitted with a restricted flow insert | · KEEP OUT OF REACH OF CHILDREN. [a] |
Mefenamic acid NB: entry amended in Schedule 2 | When the preparation is indicated exclusively for the treatment of dysmenorrhoea | · Do not use [this product/insert name of product] if you have a stomach ulcer. [j] · Do not use [this product/insert name of product] if you are allergic to mefenamic acid or other anti-inflammatory medicines. [j] · Unless a doctor has told you to, do not use [this product/insert name of product] if you have asthma. [j] · either - Unless a doctor has told you to, do not use [this product/insert name of product] with other medicines containing mefenamic acid or other anti-inflammatory medicines. [j] or - Unless advised by your doctor or pharmacist, do not use [this product/insert name of product] with other products containing mefenamic acid, aspirin or other anti-inflammatory medicines or with medicines that you are taking regularly. [j] · If you get an allergic reaction, stop taking and see your doctor immediately. [j] · Do not use for more than a few days at a time unless a doctor has told you to. Do not exceed the recommended dose. Excessive use can be harmful. [j] |
Melaleuca oil | For the purpose of exclusion from the schedules to the SUSMP when: a. in preparations containing more than 25 per cent of melaleuca oil; and b. when packed in containers having: i. a nominal capacity of 15 millilitres or less, fitted with a restricted flow insert; or ii. a nominal capacity of 25 millilitres or less, fitted with a restricted flow insert and child-resistant closure | · KEEP OUT OF REACH OF CHILDREN. [a] · NOT TO BE TAKEN. [a] |
Methoxamine | In nasal decongestant preparations for topical use | · If congestion persists, consult your doctor or pharmacist. [j] |
Miconazole | In preparations for vaginal use | · Seek medical advice before first course of treatment. [j] · See a doctor if you are pregnant or diabetic. [j] · See a doctor if no better after [Insert number of days as per approved Product Information] days. [j] · See a doctor if problem returns. [j] |
Naphazoline NB: entry amended in Schedule 2 | In nasal decongestant preparations for topical use | · If congestion persists, consult your doctor or pharmacist. [j] |
Naproxen (Entry 1 of 2) NB: entry amended in Schedule 2 | When the preparation is indicated exclusively for the treatment of dysmenorrhoea | · Do not use [this product/insert name of product] if you have a stomach ulcer. [j] · Do not use [this product/insert name of product] if you are allergic to naproxen or other anti-inflammatory medicines. [j] · Unless a doctor has told you to, do not use [this product/insert name of product] if you have asthma. [j] · either - Unless a doctor has told you to, do not use [this product/insert name of product] with other medicines containing naproxen or other anti-inflammatory medicines. [j] or - Unless advised by your doctor or pharmacist, do not use [this product/insert name of product] with other products containing naproxen, aspirin or other anti-inflammatory medicines or with medicines that you are taking regularly. [j] · If you get an allergic reaction, stop taking and see your doctor immediately. [j] · Do not use for more than a few days at a time unless a doctor has told you to. Do not exceed the recommended dose. Excessive use can be harmful. [j] |
Naproxen (Entry 2 of 2) NB: entry amended in Schedule 2 | When the preparation is NOT indicated exclusively for the treatment of dysmenorrhoea | · Do not use [this product/insert name of product] if you have a stomach ulcer. [j] · Do not use [this product/insert name of product] if you are allergic to naproxen or other anti-inflammatory medicines. [j] · Unless a doctor has told you to, do not use [this product/insert name of product] if you have asthma. [j] · either - Unless a doctor has told you to, do not use [this product/insert name of product] with other medicines containing naproxen or other anti-inflammatory medicines. [j] or - Unless advised by your doctor or pharmacist, do not use [this product/insert name of product] with other products containing naproxen, aspirin or other anti-inflammatory medicines or with medicines that you are taking regularly. [j] · If you get an allergic reaction, stop taking and see your doctor immediately. [j] · Do not use for more than a few days at a time unless a doctor has told you to. Do not exceed the recommended dose. Excessive use can be harmful. [j] · Do not use [this product/insert name of product] during the first 6 months of pregnancy, except on doctor’s advice. Do not use at all during the last 3 months of pregnancy. [j] |
Nizatidine | In Schedule 2 to the SUSMP | · CAUTION - This preparation is for the relief of minor and temporary ailments and should be used strictly as directed. [j] · If symptoms persist or recur within two weeks of completing the course, consult a doctor. [j] |
Nutmeg oil | For the purpose of exclusion from the schedules to the SUSMP when: a. in preparations containing more than 50 per cent of nutmeg oil; and b. packed in containers having a nominal capacity of 25 millilitres or less, fitted with a restricted flow insert | · KEEP OUT OF REACH OF CHILDREN. [a] |
Nystatin | In preparations for vaginal use | · See a doctor if you are pregnant or diabetic. [j] · Seek medical advice before first course of treatment. [j] · If getting better, keep using for [insert number of days as per approved Product Information] days. [j] · See a doctor if no better after [Insert number of days as per approved Product Information] days. [j] · See a doctor if problem returns. [j] |
Orange oil (bitter) | For the purpose of exclusion from the schedules to the SUSMP | · Application to skin may increase sensitivity to sunlight. [j] |
Oxymetazoline NB: entry amended in Schedule 2 | In nasal decongestant preparations for topical use | · If congestion persists, consult your doctor or pharmacist. [j] |
Paracetamol (Entry 1 of 2) | For the purpose of exclusion from the schedules to the SUSMP | · Adults: Keep to the recommended dose. Do not take this medicine for longer than a few days at a time unless advised to by a doctor. · Children and adolescents: Keep to the recommended dose. Do not give this medicine for longer than 48 hours at a time unless advised to by a doctor. · If an overdose is taken or suspected, ring the Poisons Information Centre (Australia 13 11 26, New Zealand 0800 764 766) or go to hospital straight away even if you feel well because of the risk of delayed, serious liver damage. · Do not take with other products containing paracetamol, unless advised to do so by a doctor or pharmacist. |
Paracetamol (Entry 2 of 2) | In a schedule to the SUSMP | · - Adults: Keep to the recommended dose. Do not take this medicine for longer than a few days at a time unless advised to by a doctor. [j] and / or - Children and adolescents: Keep to the recommended dose. Do not give this medicine for longer than 48 hours at a time unless advised to by a doctor. [j] · If an overdose is taken or suspected, ring the Poisons Information Centre (Australia 13 11 26, New Zealand 0800 764 766) or go to hospital straight away even if you feel well because of the risk of delayed, serious liver damage. [j] · Do not take with other products containing paracetamol, unless advised to do so by a doctor or pharmacist. [j] |
Paullinia cupana | In listed medicines | · The goods contain caffeine. · Each [insert name of dosage unit] contains [insert quantity] of caffeine. |
Pennyroyal oil | For the purpose of exclusion from the schedules to the SUSMP when: a. in preparations containing more than 4 per cent of d-pulegone; and b. when packed in containers having a nominal capacity of 15 millilitres or less, fitted with a restricted flow insert and child-resistant closure | · KEEP OUT OF REACH OF CHILDREN. [a] · NOT TO BE TAKEN. [a] |
Permanganates | When included in a schedule to the SUSMP | · either - READ SAFETY DIRECTIONS [f] or - READ SAFETY DIRECTIONS BEFORE OPENING AND USING. [f] · SAFETY DIRECTIONS Corrosive [j] Avoid contact of the crystals or strong solutions with the eyes, mouth, nose and other mucous membranes. [h] |
Phenol and any other homologue of phenol. | When included in a schedule to the SUSMP | · either - READ SAFETY DIRECTIONS [f] or - READ SAFETY DIRECTIONS BEFORE OPENING AND USING. [f] · SAFETY DIRECTIONS Avoid contact with eyes [h] Avoid contact with skin [h] · DO NOT SWALLOW. [g] |
Phenylalanine | In listed medicines for oral or sublingual administration, the MRDD of which contains more than 500 milligrams of phenylalanine | · Do not use if pregnant or likely to become pregnant. |
Phenylephrine NB: see new entries in Schedule 2 | In nasal decongestant preparations for topical use | · If congestion persists, consult your doctor or pharmacist. [j] |
Piper methysticum (Entry 1 of 2) | In listed medicines for oral use containing more than 25 mg of kavalactones per dose | · Not recommended for use by pregnant or lactating women. · WARNING: Not for prolonged use. · If symptoms persist, seek advice from a health care practitioner. · May harm the liver. |
Piper methysticum (Entry 2 of 2) | For the purpose of exclusion from the schedules to the SUSMP in medicines for oral use | · Not recommended for use by pregnant or lactating women. · WARNING: Not for prolonged use. · May harm the liver. |
Podophyllin (Entry 1 of 2) | In liquid preparations other than preparations specifically for use on the anal or genital areas | · WARNING - Do not use on face or on anal or genital areas except on doctor’s advice. [j] |
Podophyllin (Entry 1 of 2) | In solid or semi-solid preparations other than preparations specifically for use on the anal or genital areas. | · WARNING - Do not use on face or on anal or genital areas. [j] |
Podophyllotoxin (Entry 1 of 2) | In liquid preparations other than preparations specifically for use on the anal or genital areas | · WARNING - Do not use on face or on anal or genital areas except on doctor’s advice. [j] |
Podophyllotoxin (Entry 2 of 2) | In solid or semi-solid preparations other than preparations specifically for use on the anal or genital areas | · WARNING - Do not use on face or on anal or genital areas. [j] |
Potassium hydroxide (Entry 1 of 3) | When included in a schedule to the SUSMP, in preparations containing 0.5 per cent OR LESS of potassium hydroxide | · either - READ SAFETY DIRECTIONS [f] or - READ SAFETY DIRECTIONS BEFORE OPENING AND USING. [f] · SAFETY DIRECTIONS Irritant [j] Avoid contact with eyes [h] Avoid contact with skin [h] Wash hands after use. [h] · DO NOT SWALLOW. [g] |
Potassium hydroxide (Entry 2 of 3) | When included in a schedule to the SUSMP, in solid preparations containing MORE THAN 0.5 per cent of potassium hydroxide | · either - READ SAFETY DIRECTIONS [f] or - READ SAFETY DIRECTIONS BEFORE OPENING AND USING. [f] · SAFETY DIRECTIONS Corrosive [j] May produce severe burns [j] Attacks skin and eyes [j] Wear eye protection when mixing or using [h] Wear protective gloves when mixing or using [h] Do not mix with hot water. [h] |
Potassium hydroxide (Entry 3 of 3) | When included in a schedule to the SUSMP, in liquid preparations containing MORE THAN 0.5 per cent of potassium hydroxide | · either - READ SAFETY DIRECTIONS [f] or - READ SAFETY DIRECTIONS BEFORE OPENING AND USING. [f] · SAFETY DIRECTIONS Corrosive [j] May produce severe burns [j] Attacks skin and eyes [j] Wear eye protection when mixing or using [h] Wear protective gloves when mixing or using. [h] |
Propolis (Entry 1 of 2) | In listed medicines for internal use | · WARNING: Propolis may cause allergic reactions. If irritation or swelling of the mouth or throat occurs - discontinue use. |
Propolis (Entry 2 of 2) | In listed medicines for external use | · WARNING: Propolis may cause skin irritation. Test before use. |
Pyridoxal (see also Vitamins) NB: entry amended in Schedule 2 | For the purpose of exclusion from the schedules to the SUSMP when in SINGLE‑INGREDIENT preparations containing more than 50 milligrams of pyridoxal per recommended daily dose | either · WARNING – Stop taking this medication if you experience tingling, burning or numbness and see your healthcare practitioner as soon as possible. or · WARNING – This [medication]/ [product contains pyridoxal which] may be dangerous when used in large amounts or for a long time. |
Pyridoxal (see also Vitamins) NB: entry amended in Schedule 2 | For the purpose of exclusion from the schedules to the SUSMP when in MULTI‑INGREDIENT preparations containing more than 50 milligrams of pyridoxal per recommended daily dose | either · WARNING – Stop taking this medication if you experience tingling, burning or numbness and see your healthcare practitioner as soon as possible. Contains vitamin B6. or · WARNING – This [medication]/ [product contains pyridoxal which] may be dangerous when used in large amounts or for a long time. |
Pyridoxine (see also Vitamins) NB: entry amended in Schedule 2 | For the purpose of exclusion from the schedules to the SUSMP when in SINGLE‑INGREDIENT preparations containing more than 50 milligrams of pyridoxine per recommended daily dose | either · WARNING – Stop taking this medication if you experience tingling, burning or numbness and see your healthcare practitioner as soon as possible. or · WARNING – This [medication]/ [product contains pyridoxine which] may be dangerous when used in large amounts or for a long time. |
Pyridoxine (see also Vitamins) NB: entry amended in Schedule 2 | For the purpose of exclusion from the schedules to the SUSMP when in MULTI‑INGREDIENT preparations containing more than 50 milligrams of pyridoxine per recommended daily dose | either · WARNING – Stop taking this medication if you experience tingling, burning or numbness and see your healthcare practitioner as soon as possible. Contains vitamin B6. or · WARNING – This [medication]/ [product contains pyridoxine which] may be dangerous when used in large amounts or for a long time. |
Pyrithione zinc | For the purpose of exclusion from the schedules to the SUSMP when in shampoos containing 2 per cent or less of pyrithione zinc | either · Keep out of eyes. or · If in eyes, rinse well with water. |
Ranitidine | In medicines for oral use | · CAUTION - This preparation is for the relief of minor and temporary ailments and should be used strictly as directed. [j] · If symptoms persist or recur within two weeks of completing the course, consult a doctor. [j] |
Royal jelly NB: Entry amended in Schedule 2 | In listed medicines | · Not to be taken by asthma and allergy sufferers.[k] [l] · This product contains royal jelly which has been reported to cause severe allergic reactions and in rare cases fatalities – especially in asthma and allergy sufferers. |
Safrole | When included in a schedule to the SUSMP | · either - READ SAFETY DIRECTIONS [f] or - READ SAFETY DIRECTIONS BEFORE OPENING AND USING. [f] · SAFETY DIRECTIONS Avoid contact with eyes. [h] |
Sage oil | For the purpose of exclusion from the schedules to the SUSMP when: a. in preparations containing more than 4 per cent of thujone; and b. packed in containers having a nominal capacity of 15 millilitres or less, fitted with a restricted flow insert and child-resistant closure | · KEEP OUT OF REACH OF CHILDREN. [a] · NOT TO BE TAKEN. [a] |
Salbutamol | In metered aerosols or in dry powder formulations | · This preparation should be part of an overall treatment plan regularly assessed with your doctor. [j] |
Sassafras oil | When included in a schedule to the SUSMP | · either - READ SAFETY DIRECTIONS [f] or - READ SAFETY DIRECTIONS BEFORE OPENING AND USING. [f] · SAFETY DIRECTIONS Avoid contact with eyes. [h] |
Selenium yeast – high NB: Entry amended in Schedule 2 | In listed medicines | · This product contains selenium which is toxic in high doses. · A daily dose of 150 micrograms for adults of selenium from dietary supplements should not be exceeded. |
Selenocysteine NB: Entry amended in Schedule 2 | In listed medicines | · This product contains selenium which is toxic in high doses. · A daily dose of 150 micrograms for adults of selenium from dietary supplements should not be exceeded. |
Selenomethionine NB: Entry amended in Schedule 2 | In listed medicines | · This product contains selenium which is toxic in high doses. · A daily dose of 150 micrograms for adults of selenium from dietary supplements should not be exceeded. |
Shark cartilage | In listed medicines | · Children, pregnant or breastfeeding women, and those who have recently had a heart attack, surgery or a major accident should not consume this product without medical advice. |
Silver (see also Silver salts) | For the purpose of exclusion from the schedules to the SUSMP when: a. in chewing gum containing 5 milligrams or less of silver per dosage unit; or b. in solutions for oral use containing 0.3 per cent or less of silver | · Overuse may stain skin or mouth. |
Silver salts (see also Silver) | In smoking deterrents | · WARNING - Overuse may stain the skin or mouth. [j] |
Sodium fluoride | In preparation for oral ingestion when in Schedule 2 of the SUSMP | · Use of this product is not necessary in areas supplied with fluoridated water. [j] |
Sodium hydroxide (Entry 1 of 3) | When included in a schedule to the SUSMP in preparations containing 0.5 per cent OR LESS of sodium hydroxide | · either - READ SAFETY DIRECTIONS [f] or - READ SAFETY DIRECTIONS BEFORE OPENING AND USING. [f] · SAFETY DIRECTIONS Irritant [j] Avoid contact with eyes [h] Avoid contact with skin [h] Wash hands after use. [h] · DO NOT SWALLOW. [g] |
Sodium hydroxide (Entry 2 of 3) | When included in a schedule to the SUSMP in solid preparations containing MORE THAN 0.5 per cent of sodium hydroxide | · either - READ SAFETY DIRECTIONS [f] or - READ SAFETY DIRECTIONS BEFORE OPENING AND USING. [f] · SAFETY DIRECTIONS Corrosive [j] May produce severe burns [j] Attacks skin and eyes [j] Wear eye protection when mixing or using [h] Wear protective gloves when mixing or using [h] Do not mix with hot water. [h] |
Sodium hydroxide (Entry 3 of 3) | When included in a schedule to the SUSMP in liquid preparations containing MORE THAN 0.5 per cent of sodium hydroxide | · Either - READ SAFETY DIRECTIONS [f] or - READ SAFETY DIRECTIONS BEFORE OPENING AND USING. [f] · SAFETY DIRECTIONS Corrosive [j] May produce severe burns [j] Attacks skin and eyes [j] Wear eye protection when mixing or using [h] Wear protective gloves when mixing or using. [h] |
Sodium selenate NB: Entry amended in Schedule 2 | In listed medicines | · This product contains selenium which is toxic in high doses. · A daily dose of 150 micrograms for adults of selenium from dietary supplements should not be exceeded. |
Sodium selenite NB: Entry amended in Schedule 2 | In listed medicines | · This product contains selenium which is toxic in high doses. · A daily dose of 150 micrograms for adults of selenium from dietary supplements should not be exceeded. |
Sodium sulfate | In listed medicines | · This preparation may have a laxative effect. |
(S)-S-Adenosylmethionine | In listed medicines, in the form of sulfate salts, tosylate salts or mixed sulfate and tosylate salts | · Individuals who are using prescription anti-depressants or suffer from bipolar depression should not use this product unless under the supervision of a healthcare practitioner. |
Star anise oil | For the purpose of exclusion from the schedules to the SUSMP when: a. in preparations containing more than 50 per cent of star anise oil; and b. packed in containers having a nominal capacity of 50 millilitres or less, fitted with a restricted flow insert | · KEEP OUT OF REACH OF CHILDREN. [a] |
Sugar cane wax alcohols | In listed medicines | · Not recommended for use by pregnant or lactating women. |
Symphytum spp. | In Schedule 5 to the SUSMP | · either - READ SAFETY DIRECTIONS [f] or - READ SAFETY DIRECTIONS BEFORE OPENING AND USING. [f] · SAFETY DIRECTIONS Do not use on broken skin [h] Do not use under occlusive dressing [h] · DO NOT SWALLOW. [g] |
Terbutaline | In metered aerosols | · This preparation should be part of an overall treatment plan regularly assessed with your doctor. [j] |
Tetrahydrozoline NB: entry amended in Schedule 2 | In nasal decongestant preparations for topical use | · If congestion persists, consult your doctor or pharmacist. [j] |
Thyme oil | For the purpose of exclusion from the schedules to the SUSMP when: a. in preparations containing more than 50 per cent of thyme oil; and b. packed in containers having a nominal capacity of 25 millilitres or less, fitted with a restricted flow insert | · KEEP OUT OF REACH OF CHILDREN. [a] |
Tramazoline NB: entry amended in Schedule 2 | In nasal decongestant preparations for topical use | · If congestion persists, consult your doctor or pharmacist. [j] |
Triamcinolone | In topical preparations for the treatment of mouth ulcers | Either · See a [doctor / doctor or dentist] if no better after [Insert number of days as per approved Product Information] days. [j] or · If symptoms persist beyond 5 days consult a [doctor / doctor or dentist]. [j] |
Tymazoline | In nasal decongestant preparations for topical use | · If congestion persists, consult your doctor or pharmacist. |
Ubidecarenone | In listed medicines | · Not to be taken if on warfarin therapy, without medical advice. |
Vitamin A (see also Vitamins) | In preparations for internal use that are labelled for adult use, containing MORE THAN: a. 33 micrograms retinol equivalents of vitamin A per dosage unit of a divided preparation; or b. 33 micrograms retinol equivalents of vitamin A per gram of an undivided preparation | · The recommended daily amount of vitamin A from all sources is 700 micrograms retinol equivalents for women and 900 micrograms retinol equivalents for men. [e] · WARNING – When taken in excess of 3000 micrograms retinol equivalents, vitamin A can cause birth defects. [c], [e] · If you are pregnant, or considering becoming pregnant, do not take vitamin A supplements without consulting your doctor or pharmacist [c], [e] |
Vitamins (see also: Pyridoxal Pyridoxine Vitamin A) | In listed medicines | Either · Vitamins can only be of assistance if the dietary vitamin intake is inadequate. or · Vitamin supplements should not replace a balanced diet. |
Xylometazoline NB: entry amended in Schedule 2 | In nasal decongestant preparations for topical use | · If congestion persists, consult your doctor or pharmacist. [j] |
Yeast – high selenium NB: Entry amended in Schedule 2 | In listed medicines | · This product contains selenium which is toxic in high doses · A daily dose of 150 micrograms for adults of selenium from dietary supplements should not be exceeded. |
Zinc chloride | When included in a schedule to the SUSMP | · either - READ SAFETY DIRECTIONS [f] or - READ SAFETY DIRECTIONS BEFORE OPENING AND USING. [f] · SAFETY DIRECTIONS Avoid contact with eyes [h] Avoid contact with skin. [h] |
Zinc compounds | In preparations for internal use with a recommended daily dose of more than 25 milligrams of zinc | either · WARNING - This medication may be dangerous when used in large amounts or for a long period. or · WARNING - Contains zinc, which may be dangerous when used in large amounts or for a long period. |
Zinc sulfate | When included in Schedule 6 to the SUSMP | · either - READ SAFETY DIRECTIONS [f] or - READ SAFETY DIRECTIONS BEFORE OPENING AND USING. [f] · SAFETY DIRECTIONS Avoid contact with eyes [h] Avoid contact with skin. [h] |
Zingiber officinale | In listed medicines: a. when the extraction ratio is 25:1 or higher; and b. when the equivalent dry weight per dosage unit is 2 grams or higher | · Individuals taking anticoagulants should seek medical advice before taking this product. · Individuals at risk of bleeding problems should seek advice from their healthcare practitioner prior to taking this product. |